Retraction: Down-regulation of microRNA-26b modulate non-small cell lung cancer cells chemoresistance and migration through the association of PTEN (Acta Biochim Biophys Sin (2015) (530–538) DOI: 10.1093/abbs/gmv046);Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN

Acta Biochimica et Biophysica Sinica

Volumn 47, Issue 7, 2015, Pages 530-538

  Liang, Naixin ^a   Zhou, Xiaoyun ^a   Zhao, Ming ^b   Zhao, Dachun ^a   Zhu, Zhaohui ^a   Li, Shanqing ^a   Yang, Huaxia ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

cisplatin; migration; miR 26b; NSCLC; PTEN

Indexed keywords

MICRORNA; MIRN26A MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

CELL PROLIFERATION; DOWN REGULATION; DRUG RESISTANCE; GENETICS; HUMAN; LUNG TUMOR; METASTASIS; NON SMALL CELL LUNG CANCER; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM METASTASIS; PTEN PHOSPHOHYDROLASE; UP-REGULATION;

EID: 84936869254     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmaa171     Document Type: Erratum

References (25)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CACancer J Clin 2013, 63: 11-30.
2. Al-Shahrabani F, Vallbohmer D, Angenendt S, Knoefel WT. Surgical strategies in the therapy of non-small cell lung cancer.World J Clin Oncol 2014, 5: 595-603.
3. Nguyen KS, Neal JW, Wakelee H. Review of the current targeted therapies for non-small-cell lung cancer. World J Clin Oncol 2014, 5: 576-587.
4. Tsuboi M, Ohira T, Saji H, Miyajima K, Kajiwara N, Uchida O, Usuda J, et al. The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2007, 13: 73-77.
5. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007, 608: 1-22.
6. Zhang R, Su B. Small but influential: the role of microRNAs on gene regulatory network and 3′UTR evolution. J Genet Genomics 2009, 36: 1-6.
7. Maziere P, Enright AJ. Prediction of microRNA targets. Drug Discov Today 2007, 12: 452-458.
8. Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005, 11: 1753-1761.
9. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007, 39: 673-677.
10. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007, 302: 1-12.
11. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Brit J Cancer 2006, 94: 776-780.
12. Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F, Visone R, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103: 2257-2261.
13. Huang S, He X. The role of microRNAs in liver cancer progression. Brit J Cancer 2011, 104: 235-240.
14. Wang Y, Lee CG. MicroRNA and cancer-focus on apoptosis. J Cell Mol Med 2009, 13: 12-23.
15. Aleckovic M, Kang Y. Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta 2014, 1855: 24-42.
16. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 2009, 9: 293-302.
17. Liu X-X, Li X-J, Zhang B, Liang Y-J, Zhou C-X, Cao D-X, He M, et al. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett 2011, 585: 1363-1367.
18. Palumbo T, Faucz FR, Azevedo M, Xekouki P, Iliopoulos D, Stratakis CA. Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway. Oncogene 2012, 32: 1651-1659.
19. GaoW, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 2010, 64: 399-408.
20. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15: 356-362.
21. Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 2002, 8: 1178-1184.
22. Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q, Xu K. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 2012, 1822: 1692-1704.
23. Liu ZL,Wang H, Liu J,Wang ZX. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 2013, 372: 35-45.
24. Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 2010, 411: 846-852.
25. Arora H, Qureshi R, Park AK, Park WY. Coordinated regulation of ATF2 by miR-26b in gamma-irradiated lung cancer cells. PLoS ONE 2011, 6: e23802.